Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy

NCT02401490 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT02401490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02401490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2015
Completion date
March 31, 2018
Enrollment
128 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatic encephalopathy